Company Dipexium Pharmaceuticals Inc Nasdaq

PLx Pharma Winddown Corp., formerly PLx Pharma Inc., is a commercial-stage drug delivery platform technology company. The Company is focused on improving how and where active pharmaceutical ingredients (APIs) are absorbed in the gastrointestinal (GI) tract via its clinically validated and patent-protected PLxGuard technology. The Company has two Food and Drug Administration (FDA) approved products, VAZALORE 81 mg and VAZALORE 325 mg (VAZALORE), which are liquid-filled aspirin capsules for over-the-counter distribution (OTC). The Company markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation. It also screens additional compounds outside the NSAID category for possible development using its PLxGuard drug delivery platform.